A Double-Blind, Placebo-Controlled (Sham Surgery), Randomized, Multicenter Study Evaluating CERE-110 Gene Delivery in Subjects with Mild to Moderate Alzheimer's Disease (CERE 110-3)

Grant

Awarded By

Total Award Amount

  • 394500.00

    • Direct Costs

  • 313096.00

    • Sponsor Award Id

  • ADC

    • Contributor

  • David Geldmacher   Principal Investigator  
  • Harrison Walker   Investigator  
  • Khurram Bashir   Investigator  
  • Marissa Natelson Love   Investigator  
  • Ray Watts   Investigator